$A News

Agilent Research Catalyst Award Presented to Eastern Institute of Technology, Ningbo

Agilent to Announce Third-Quarter Fiscal Year 2026 Financial Results on Aug. 26

Is Agilent Technologies (A) Undervalued Following Its FDA Approval For OPDIVO Companion Diagnostics?

What to Expect From Agilent Technologies' Q3 2026 Earnings Report

Agilent Technologies shares are trading higher after the company announced it has received EU certification for PD-L1 IHC 22C3 pharmDx, in identifying epithelial ovarian, fallopian tube, or primary peritoneal carcinoma.

Agilent Technologies Receives EU Certification For Code SK006 As Companion Diagnostic To Aid In Identifying Patients With Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Carcinoma

Agilent Increases Its Investment in HALO X-ray Technologies

Agilent Technologies (NYSE:A) Shows Strong Breakout Setup with Top-Tier Technical Ratings

Agilent (A): Buy, Sell, or Hold Post Q1 Earnings?

Agilent Strengthens Biopharma Growth Prospects With AI Expansion

Is Agilent Technologies, Inc. (A) Stock Positioned for Growth as Life Sciences Sector Trends Stabilize?

Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis

Agilent (A) Stock Looks Below Fair Value On Cash Flow

Evercore ISI Group Maintains Outperform on Agilent Technologies, Raises Price Target to $148

Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight

Why Is Agilent (A) Up 0.1% Since Last Earnings Report?

Agilent finalizes Biocare Medical takeover

Bernstein Reinstates Outperform on Agilent Technologies, Announces $155 Price Target

Agilent (A) Stock Trades Up, Here Is Why

Agilent Technologies, Inc. (A) Initiated at Neutral With $150 Price Target by Piper Sandler